Lymphoma News Today

January 18, 2019January 19, 2019

Tyvyt, PD-1 Inhibitor Newly Approved in China, Showed Efficacy Similar to Opdivo and Keytruda, Trial Data Show

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site The immune checkpoint inhibitor Tyvyt (sintilimab injection) reduced ... Read more

January 17, 2019January 17, 2019

FDA Grants Breakthrough Therapy Designation to Zanubrutinib for Mantle Cell Lymphoma

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) granted ... Read more

January 15, 2019January 16, 2019

Volcani Center to Request Patent Coverage for Cannabis-based CTCL Therapy

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site Israel’s Volcani Center plans to submit new patent applications covering ... Read more

January 14, 2019January 14, 2019

Burkitt’s Lymphoma/Leukemia Patients Being Recruited for CPI-613 Phase 2 Trial

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site Rafael Pharmaceuticals is currently enrolling patients with relapsed ... Read more

January 11, 2019January 11, 2019

Epizyme Planning to Request FDA’s Accelerated Approval of Tazemetostat for Follicular Lymphoma Patients

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site Epizyme plans to ask the U.S. Food and Drug ... Read more

January 11, 2019January 11, 2019

Happy ‘Diagnosiversary’ to Me

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site On Jan. 15, I celebrate my “diagnosiversary” marking ... Read more

January 10, 2019January 10, 2019

Adcetris Not Cost-effective as Second-line Therapy for Some CTCL, U.K. Board Rules

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site The United Kingdom’s National Institute for Health and ... Read more

January 9, 2019January 9, 2019

Imbruvica-Gazyva Therapy Extends Survival Without Disease Progression in CLL/SLL Patients, Phase 3 Study Shows

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site First-line treatment with Imbruvica (ibrutinib) plus Gazyva (obinutuzumab) significantly ... Read more

January 8, 2019January 8, 2019

Tyvyt Approved in China for Previously Treated Classical Hodgkin’s Lymphoma

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site Tyvyt (sintilimab injection), an immune checkpoint inhibitor jointly ... Read more

January 7, 2019January 7, 2019

Sterile Kindergarten Uplifts Spirits of Kids With Cancer in Israel

Lymphoma News Today

This post was originally published on this siteThis post was originally published on this site This story originally appeared in the Times of ... Read more